GlaxoSmithKline (GSK) and Miltenyi Biotech said they will partner to develop new cell and gene therapies through a collaboration whose value was not disclosed.
The collaboration is designed to combine GSK’s expertise in developing cell- and gene therapy–based treatments with Miltenyi Biotec’s global leadership in cell processing and related technologies in cell therapy, the companies said.
{iframe}http://www.genengnews.com/gen-news-highlights/gsk-miltenyi-biotec-to-partner-on-cell-gene-therapies/81252488{/iframe}